- Rev. Al Sharpton’s Easter message: Politically ‘crucified’ Obama has risen again
- Supreme Court to weigh challenge to ban on campaign lies
- UNICEF launches ‘Mr. Poo’ mascot in India to curb public defecation
- Teen taking selfie by train: ‘Wow, that guy just kicked me in the head’
- Goodbye, Afghanistan — hello, Africa: Air Force sees resource shift as U.S. exits Middle East
- Iran mulls ban on vasectomies, decrease on abortions to bolster population
- CNN op-ed claims right-wingers ‘more deadly than jihadists’
- Classes resume at high school rocked by stabbings
- ABC News accuses Center for Public Integrity of stealing Pulitzer-winning work
- Law firm that cleared N.J. Gov. Christie in ‘Bridgegate’ gave 10K to RGA, which he heads
Reeling Texas cancer agency OK’d faulty $11M award
AUSTIN, TEXAS (AP) - Leaders of Texas’ embattled $3 billion cancer-fighting effort approved an $11 million grant to a biomedical company even though the proposal wasn’t reviewed, according to an internal audit that deepens the troubles of a state agency that has been denounced in recent months by some of the world’s top scientists.
The discovery was uncovered during an internal review of the Cancer Prevention and Research Institute of Texas, and its grant to Peloton Therapeutics Inc. in 2010 was among the first it handed out. The Dallas-based company’s commercialization award remains one of agency’s largest taxpayer-funded grants to date.
The Associated Press on Thursday first reported the audit’s findings, which were later announced by the agency.
Tim Kutzkey, Peloton’s acting chief executive officer, declined comment and referred questions to CPRIT. In a statement, the agency said the company was unaware that “CPRIT processes had not been followed.”
The cancer institute is home to the nation’s second largest pot of cancer-research money, behind only the National Institutes of Health, and has awarded nearly $700 million. But it has come under intensifying scrutiny as several scientists, including two Nobel laureates, resigned in protest claiming the agency was charting a new politically driven path that put commercial interests before science.
CPRIT said the internal review did not uncover problems with any other commercialization awards.
The Peloton revelation is the latest blow to CPRIT, which launched in 2009 to widespread acclaim among scientists and cancer survivors but has spent the past year unraveling. Dozens of scientists have resigned from the agency’s peer review panels en masse in recent weeks, some of whom criticized the fund for “hucksterism” and “suspicion of favoritism” on their way out the door.
Pelton’s application would have been presented to the agency’s oversight committee by Jerry Cobbs, the agency’s chief commercialization officer. Cobbs announced his resignation this month, and his last day was set for Friday.
Members of the oversight committee are appointed by Gov. Rick Perry and other state elected leaders. The panel has the final say on whether an award is funded, but under agency rules, all applications must be reviewed by an outside panel of peer reviewers who evaluate the scientific and commercial merits of the proposal.
The agency’s statement did not explain how Pelton’s application made it through the process without anyone noticing that a review never took place. It only said that Cobbs “improperly included” the proposal in a slate of other recommendations to the oversight committee in 2010.
Attempts by the AP to reach Cobbs were not immediately successful Thursday evening.
Bill Gimson, the executive director of CPRIT who vowed that his reeling agency would recover from the growing onslaught of criticism at its annual conference in October, said in response to the audit’s findings that the agency must have the state’s trust.
“We proactively initiated this comprehensive review in the effort to be transparent and ensure good stewardship,” Gimson said.
Peloton’s funding has been halted and the company’s application is undergoing a second review, the agency said.
According to Peloton’s most recent annual report to the CPRIT, which was obtained by AP, the company has attracted $18 million in outside investments since it was founded in 2010 by Steven McKnight, chairman of the biochemistry department at the University of Texas Southwestern Medical Center.
TWT Video Picks
By returning to Christian roots, the nation can achieve greatness once again
- 'Culture of intimidation' seen in Nevada ranch standoff
- GOP writes legislation to deny Attorney General Eric Holder his salary
- Nevada Bundy ranch standoff could leave dirt on Harry Reid reputation
- U.S. Navy to turn seawater into jet fuel
- CARSON: Recovering Tocqueville's vision of American exceptionalism
- U.S. military on high alert as Ukraine troops trade gunfire with pro-Russian militants
- Fuel-filled wings, ability to swarm: Pentagon offers glimpse at future of drone fleet
- Secret U.S. assessments show Afghanistan not ready to govern on own
- CNN op-ed claims right-wingers 'more deadly than jihadists'
- Josh Romney swipes Harry Reid with photo tweet of dad paying taxes 'your paycheck'
Celebrity deaths in 2014
Top 10 handguns in the U.S.